Aldesleukin Completed Phase 1 Trials for Type 1 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00525889Proleukin and Rapamune in Type 1 Diabetes